R. Zampino, A. Boemio, and C. Sagnelli, Hepatitis B virus burden in developing countries, World Journal of Gastroenterology, vol.21, issue.42, pp.11941-11953, 2015.

, Hepatitis B vaccine birthdose practices in a country where hepatitis B is endemic -Laos, Centers for Disease Control and Prevention (CDC), vol.62, pp.587-590, 2013.

A. P. Black, P. Nouanthong, and N. Nanthavong, Hepatitis B virus in the Lao People's Democratic Republic: a cross sectional serosurvey in different cohorts, BMC Infectious Diseases, vol.14, p.457, 2014.

N. H. Kong and P. K. Chow, Conducting randomised controlled trials across countries with disparate levels of socioeconomic development: The experience of the Asia-Pacific Hepatocellular Carcinoma Trials Group, Contemporary Clinical Trials, vol.36, issue.2, pp.682-686, 2013.

, Globocan 2012 -Home

J. M. Llovet, A. Villanueva, A. Lachenmayer, and R. S. Finn, Advances in targeted therapies for hepatocellular carcinoma in the genomic era, Nature Reviews Clinical Oncology, vol.12, issue.7, pp.408-424, 2015.

S. K. Sarin, M. Kumar, and G. K. Lau, Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update, Hepatology International, vol.10, issue.1, pp.1-98, 2015.

N. A. Terrault, N. H. Bzowej, K. Chang, J. P. Hwang, M. M. Jonas et al., AASLD guidelines for treatment of chronic hepatitis B, Hepatology, vol.63, issue.1, pp.261-283, 2016.

, Laos GDP per capita -1984-2016 -Data -Chart -Calendar -Forecast -News

B. S. Blumberg, Sex differences in response to hepatitis b virus, Arthritis & Rheumatism, vol.22, issue.11, pp.1261-1266, 1979.

J. Ferlay, I. Soerjomataram, and R. Dikshit, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, International Journal of Cancer, 2014.

J. W. Park, M. Chen, and M. Colombo, Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study, Liver International, vol.35, issue.9, pp.2155-2166, 2015.

R. X. Zhu, W. Seto, C. Lai, and M. Yuen, Epidemiology of hepatocellular carcinoma in the Asia-Pacific region, Gut and Liver, vol.10, issue.3, pp.332-339, 2016.

S. Bertani, P. Pineau, and S. Loli, An Atypical Age-Specific Pattern of Hepatocellular Carcinoma in Peru: A Threat for Andean Populations, PLoS ONE, vol.8, issue.6, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01356600

A. Marchio, S. Bertani, and T. R. Rojas, A peculiar mutation spectrum emerging from young peruvian patients with hepatocellular carcinoma, PLoS ONE, vol.9, issue.12, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01239684

E. Ruiz, T. Rojas, and F. Berrospi, Hepatocellular carcinoma surgery outcomes in the developing world: A 20-year retrospective cohort study at the National Cancer Institute of Peru, Heliyon, vol.2, issue.1, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01356598

J. D. Yang, A. Gyedu, and M. Y. Afihene, Hepatocellular carcinoma occurs at an earlier age in Africans, particularly in association with chronic Hepatitis B, American Journal of Gastroenterology, vol.110, issue.11, pp.1629-1631, 2015.

X. Chen, F. Wu, and Y. Liu, The contribution of serum hepatitis B virus load in the carcinogenesis and prognosis of hepatocellular carcinoma: Evidence from two meta-analyses, Oncotarget, vol.7, issue.31, pp.49299-49309, 2016.

J. Pawlotsky, G. Dusheiko, and A. Hatzakis, Virologic Monitoring of Hepatitis B Virus Therapy in Clinical Trials and Practice: Recommendations for a Standardized Approach, Gastroenterology, vol.134, issue.2, pp.405-415, 2008.

C. Chen, H. Yang, and U. H. Iloeje, Hepatitis B virus DNA levels and outcomes in chronic hepatitis B, Hepatology, vol.49, issue.5, pp.72-84, 2009.

H. You, Y. Kong, and J. Hou, Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B, Scientific Reports, vol.6, 2016.

P. Zhang, C. Wang, Y. Li, Y. Pan, J. Niu et al., Determination of the upper cut-off values of serum alanine aminotransferase and aspartate aminotransferase in Chinese, World Journal of Gastroenterology, vol.21, issue.8, pp.2419-2424, 2015.

P. Marcellin, T. Chang, and S. G. Lim, Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B, The New England Journal of Medicine, vol.348, issue.9, pp.808-816, 2003.

P. Marcellin, E. Gane, and M. Buti, Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study, The Lancet, vol.381, issue.9865, pp.468-475, 2013.

C. Wu, J. Lin, and H. J. Ho, Association of nucleos(T)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B -A nationwide cohort study, Gastroenterology, vol.147, issue.1, pp.143-148, 2014.

E. De-clercq and G. Li, Approved antiviral drugs over the past 50 years, Clinical Microbiology Reviews, vol.29, issue.3, pp.695-747, 2016.

, WHO -WHO Model Lists of Essential Medicines

F. Suzuki, Y. Suzuki, and A. Tsubota, Mutations of polymerase, precore and core promoter gene in hepatitis B virus during 5-year lamivudine therapy, Journal of Hepatology, vol.37, issue.6, pp.824-830, 2002.

G. Papatheodoridis, I. Vlachogiannakos, and E. Cholongitas, Discontinuation of oral antivirals in chronic hepatitis B: A systematic review, Hepatology, vol.63, issue.5, pp.1481-1492, 2016.

F. Izzo, M. Piccirillo, and V. Albino, Prospective screening increases the detection of potentially curable hepatocellular carcinoma: Results in 8900 high-risk patients, HPB, vol.15, issue.12, pp.985-990, 2013.

M. Fusco, P. Piselli, and S. Virdone, Infection with hepatitis viruses, FIB-4 index and risk of hepatocellular carcinoma in southern Italy: a population-based cohort study, Infectious Agents and Cancer, vol.11, issue.1, pp.1-8, 2016.